Latest Breaking News On - Alkermes board - Page 1 : comparemela.com

Alkermes plc: Independent Proxy Advisory Firm Glass Lewis Recommends Alkermes Shareholders Vote FOR All Seven of the Company s Highly Qualified Director Nominees

Alkermes plc: Independent Proxy Advisory Firm Glass Lewis Recommends Alkermes Shareholders Vote FOR All Seven of the Company s Highly Qualified Director Nominees
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesChris kittredge zachary tramontiChristopheri wrightSarah schlesingerBrianp mckeonShanem cookeEmily peterson alvaKatie joyceSandy coombsRichardb gaynorCatot laurencinInnisfree ma incorporatedGlass lewis peer groupLewis coCompany annual report on formBoard nominees using company

Independent Proxy Advisory Firm ISS Recommends Alkermes Shareholders Vote Against Sarissa Employees Election to Alkermes Board

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) (the Company) today announced that independent shareholder advisory firm Institutional Shareholder Services (ISS).

United statesCatot laurencinSarah schlesingerChristopheri wrightBrianp mckeonChris kittredge zachary tramontiAlex dennerRichardb gaynorShanem cookeSandy coombsEli lillySarissa alex dennerRichard gaynorKatie joyceShane cookeEmily peterson alva

Hedge Fund and Insider Trading News: Ken Griffin, Crispin Odey, Joel Greenblatt, Ancora Advisors, Sarissa Capital, Elliott Management, Clene Inc (CLNN), Asana, Inc (ASAN), and More

Proxy advisory firm Institutional Investor Services urged Alkermes (ALKS.O) shareholders to elect one of three director candidates proposed by activist hedge fund Sarissa Capital, arguing more outside.

United statesWest virginiaSarah schlesingerPhongphan shutterstockCrispin odeyRichard gaynorKen griffinHedge fund investorschronicleFinancial conduct authorityDefence firm under fireInstitutional investor servicesThree nomineesAlkermes boardSarissa capitalNew analysis saysRichest person in every state

Alkermes To Spin-Off Mural Oncology In 2H23

ALKS, $31.48, Market Capitalization: $5.2 billion), a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience .

United statesCarolinej loewArthur coxExchange commissionMorgan stanleyCompany descriptionGoodwin procterMarket capitalizationUnited states securitiesMural oncologyAlkerme boardGeneral meetingRichard popsChief executive officerBofa securitiesEnhancement plan

Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) (the Company) today issued a letter to its shareholders in connection with the Company s upcoming 2023 Annual.

Iron mountainNew yorkUnited statesDavida daglioWilda van dusenW montague cobbNancyj wysenskiEli lillyShanem cookeEmily petersonAndy wilsonRichard gaynorKatie joyceCatot laurencinFrank anders wilsonAlexander denner